Search

The parasitic copepod genus Parabrachiella is composed of 70 species, 14 of which are found in South America. The finding of new specimens of Parabrachiella mugilis from Turkey allowed us to compare the nucleotide sequences of the mitochondrial cytochrome c oxidase subunit I (COI) gene of this species with those of the South American Parabrachiella exilis and Parabrachiella platensis; all these species are parasites of mugilids. In addition, specimens of Parabrachiella fasciata, Parabrachiella oralis and Parabrachiella dispar from Chile, and Parabrachiella chevreuxi from Argentina were included in the comparison. Our results confirmed that the three Parabrachiella species parasitizing mugilids, which had been identified by morphology, are valid entities. However, P. exilis was recently synonymized with P. mugilis. The latter species showed a great genetic distance from P. exilis (16%) and was closer to Parabrachiella fasciata (13%) and to species with long posterior processes. Parabrachiella exilis and P. platensis (parasite on Mugil cephalus and Mugil liza, respectively) had a low genetic distance (9%) and Parabrachiella kabatai (parasite of Isacia conceptionis) had a low genetic distance (12-13%) from P. fasciata, P. platensis and P. exilis. In addition, the three parasitic copepods from South America have short and round posterior processes compared to other species, which have long posterior processes. Most species with long posterior processes are clustered together in a Pacific Ocean clade (P. hugu from the North Pacific Ocean), with the exception of P. chevreuxi, which has been found in the South Atlantic Ocean. This study adds seven new sequences, making a total of nine sequenced South American species of Parabrachiella., (Copyright © 2021. Published by Elsevier B.V.)

Objectives: The overall aim of this article was to present a step-by-step guideline for determining the costs associated with dengue in dengue-endemic countries of the Latin American and the Caribbean region and to illustrate how each of these steps can be applied in dengue costing studies., Methods: An expert panel was convened to develop standards for costing dengue so that over the next decade, decision makers will have access to improved information on the true cost of dengue in endemic countries of the Latin American and the Caribbean region. We described the outcome of the expert panel meeting, which resulted in the provision of a step-by-step dengue costing guideline that aims to provide direction to planners and program managers on how to estimate dengue economic burden studies, and provide a discussion forum of the methods used to cost dengue fever cases and outbreaks in a manner that should be accessible to persons with some familiarity with a cost study., Results: The guideline includes nine sequential steps: 1) definition of the scope of the study; 2) identification of the target population; 3) description of the study perspective; 4) definition of the time horizon; 5) calculation of the sample size; 6) definition of the unit of analysis; 7) identification of the cost items; 8) measurement and valuation of the cost items; and 9) handling of uncertainty. The trade-off between accurate, patient-level cost estimates and data availability constraints is discussed., Conclusions: The current guideline is the result of constructive collaboration among a multidisciplinary research team to better ascertain the true economic burden of dengue across countries of the region., (Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.)